StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Coya Therapeutics cash

Cash and short-term investments held at the end of each period.

Coya Therapeutics's cash was $35.80M at Sep 30, 2026. For fiscal 2025 it was $46.82M, up 22.1% from the year before. The highest annual figure on record is $46.82M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$46.82M+22.1%
FY2024Dec 31, 2024$38.34M+17.5%
FY2023Dec 31, 2023$32.63M+449.9%
FY2022Dec 31, 2022$5.93M+36.7%
FY2021Dec 31, 2021$4.34M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$35.80M+27.3%
Q2 FY2026Jun 30, 2026$43.18M+45.1%
Q1 FY2026Mar 31, 2026$50.72M+42.8%
Q4 FY2025Dec 31, 2025$46.82M+22.1%
Q3 FY2025Sep 30, 2025$28.13M-9.4%
Q2 FY2025Jun 30, 2025$29.76M-18.6%
Q1 FY2025Mar 31, 2025$35.53M-1.3%
Q4 FY2024Dec 31, 2024$38.34M+17.5%
Q3 FY2024Sep 30, 2024$31.06M+185.3%
Q2 FY2024Jun 30, 2024$36.58M+179.1%
Q1 FY2024Mar 31, 2024$35.99M+120.5%
Q4 FY2023Dec 31, 2023$32.63M+449.9%
Q3 FY2023Sep 30, 2023$10.89M+150.8%
Q2 FY2023Jun 30, 2023$13.10M–
Q1 FY2023Mar 31, 2023$16.32M–
Q4 FY2022Dec 31, 2022$5.93M–
Q4 FY2021Dec 31, 2021$4.34M–

More Coya Therapeutics figures

See a number that looks wrong?